Ardelyx Inc (ARDX)
5.805
-0.08
(-1.44%)
USD |
NASDAQ |
Nov 05, 11:42
Ardelyx Total Assets (Quarterly): 367.86M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 367.86M |
| June 30, 2024 | 343.49M |
| March 31, 2024 | 342.38M |
| December 31, 2023 | 297.58M |
| September 30, 2023 | 289.38M |
| June 30, 2023 | 211.20M |
| March 31, 2023 | 217.02M |
| December 31, 2022 | 190.07M |
| September 30, 2022 | 144.67M |
| June 30, 2022 | 131.61M |
| March 31, 2022 | 129.41M |
| December 31, 2021 | 149.91M |
| September 30, 2021 | 170.85M |
| June 30, 2021 | 204.98M |
| March 31, 2021 | 210.29M |
| December 31, 2020 | 201.56M |
| September 30, 2020 | 198.56M |
| June 30, 2020 | 217.34M |
| March 31, 2020 | 235.32M |
| December 31, 2019 | 259.78M |
| September 30, 2019 | 119.41M |
| June 30, 2019 | 137.98M |
| Date | Value |
|---|---|
| March 31, 2019 | 166.14M |
| December 31, 2018 | 183.33M |
| September 30, 2018 | 206.67M |
| June 30, 2018 | 228.54M |
| March 31, 2018 | 142.84M |
| December 31, 2017 | 157.90M |
| September 30, 2017 | 143.10M |
| June 30, 2017 | 164.12M |
| March 31, 2017 | 187.76M |
| December 31, 2016 | 213.13M |
| September 30, 2016 | 241.32M |
| June 30, 2016 | 155.38M |
| March 31, 2016 | 180.50M |
| December 31, 2015 | 116.95M |
| September 30, 2015 | 138.07M |
| June 30, 2015 | 148.19M |
| March 31, 2015 | 105.40M |
| December 31, 2014 | 113.41M |
| September 30, 2014 | 117.73M |
| June 30, 2014 | 123.48M |
| March 31, 2014 | 40.55M |
| December 31, 2013 | 42.90M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
129.41M
Minimum
Mar 2022
367.86M
Maximum
Sep 2024
225.66M
Average
210.75M
Median
Total Assets (Quarterly) Benchmarks
| Verve Therapeutics Inc | 700.91M |
| United Therapeutics Corp | 7.123B |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
| iBio Inc | 28.73M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 209.57M |
| Shareholders Equity (Quarterly) | 158.30M |
| Debt to Equity Ratio | 0.6362 |
| Current Ratio | 4.030 |
| Net Debt Paydown Yield | -0.90% |